Evidence map›Paper›PMID 36151080›Full record

ArticleNature communications2022

The evolutionary advantage of an aromatic clamp in plant family 3 glycoside exo-hydrolases.

Sukanya Luang, Xavier Fernández-Luengo, Alba Nin-Hill, Victor A Streltsov, Julian G Schwerdt, Santiago Alonso-Gil, James R Ketudat Cairns, Stéphanie Pradeau, Sébastien Fort, Jean-Didier Maréchal and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Crystal structure ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 5 countries.

Sukanya Luang *School of Agriculture, Food and Wine, and Waite Research Institute, University of Adelaide, Waite Research Precinct, Glen Osmond, SA, Australia.
Xavier Fernández-Luengo *Department de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Alba Nin-Hill *Department of Química Inorgànica i Orgànica and Institut de Química Teòrica i Computacional, Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-8670-9031
Victor A StreltsovThe Florey Institute, University of Melbourne, Victoria, Australia.ORCID 0000-0002-7846-4396
Julian G SchwerdtSchool of Agriculture, Food and Wine, and Waite Research Institute, University of Adelaide, Waite Research Precinct, Glen Osmond, SA, Australia.
Santiago Alonso-GilDepartment of Química Inorgànica i Orgànica and Institut de Química Teòrica i Computacional, Universitat de Barcelona, Barcelona, Spain.
James R Ketudat CairnsSchool of Chemistry, Suranaree University of Technology, Nakhon Ratchasima, Thailand.ORCID 0000-0003-3042-1626
Stéphanie PradeauUniversité Grenoble Alpes, Centre de Recherches sur les Macromolécules Végétales, Grenoble, France.ORCID 0000-0002-4213-0546
Sébastien FortUniversité Grenoble Alpes, Centre de Recherches sur les Macromolécules Végétales, Grenoble, France.ORCID 0000-0002-6133-9900
Jean-Didier MaréchalDepartment de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0002-8344-9043
Laura MasgrauDepartment de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0003-4495-508X
Carme RoviraDepartment of Química Inorgànica i Orgànica and Institut de Química Teòrica i Computacional, Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0003-1477-5010
Maria HrmovaSchool of Agriculture, Food and Wine, and Waite Research Institute, University of Adelaide, Waite Research Precinct, Glen Osmond, SA, Australia. maria.hrmova@adelaide.edu.au.ORCID 0000-0002-3545-0605
Universitat Autònoma de Barcelona · ESCentre de Recherches sur les Macromolécules Végétales · FRThe University of Adelaide · AUUniversitat de Barcelona · ESHuaiyin Normal University · CNInstitució Catalana de Recerca i Estudis Avançats · ESSuranaree University of Technology · THThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the barley β-D-glucan glucohydrolase, a glycoside hydrolase family 3 (GH3) enzyme, the Trp286/Trp434 clamp ensures β-D-glucosides binding, which is fundamental for substrate hydrolysis during plant growth and development. We employ mutagenesis, high-resolution X-ray crystallography, and multi-scale molecular modelling methods to examine the binding and conformational behaviour of isomeric β-D-glucosides during substrate-product assisted processive catalysis that operates in GH3 hydrolases. Enzyme kinetics reveals that the W434H mutant retains broad specificity, while W434A behaves as a strict (1,3)-β-D-glucosidase. Investigations of reactant movements on the nanoscale reveal that processivity is sensitive to mutation-specific alterations of the tryptophan clamp. While wild-type and W434H utilise a lateral cavity for glucose displacement and sliding of (1,3)-linked hydrolytic products through the catalytic site without dissociation, consistent with their high hydrolytic rates, W434A does not adopt processive catalysis. Phylogenomic analyses of GH3 hydrolases disclose the evolutionary advantage of the tryptophan clamp that confers broad specificity, high catalytic efficiency, and processivity.

Indexed as

Glycoside HydrolasesTryptophanCrystallography, X-RayGlucoseGlucosidasesGlucosidesGlycosidesKineticsPlantsSubstrate SpecificityGlucoseGlucosidasesGlucosidesGlycoside HydrolasesGlycosidesTryptophan

Identifiers

PMID36151080
PMCPMC9508125
OpenAlexW4296996134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.